InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.72
(
-0.22%
)
Bitcoin
59,018.54
(
-1.90%
)
Post# of 252478
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 244974

Friday, 01/06/2023 3:24:22 PM

Friday, January 06, 2023 3:24:22 PM

Post# of 252478
Additions/changes in ENTA’s most recent slide set:

• Slides 17-18 have info on the new program for dual inhibition of hMPV and RSV.

• Slide 21 has new info about EDP-235’s live-virus potency against Omicron and other strains.

• Slide 22 has new preclinical EDP-235 info from a ferret model, including data on viral transmission from animal to animal.

• Slide 25 has a graphic on the design of the (in-progress) phase-2 trial for EDP-235.

• Slide 27 has info on the new program to develop a papain-like protease inhibitor for SARS-CoV-2.

• Slide 35 has a list 2023 catalysts.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up